Ocular Therapeutix Inc Waltham, MA - 02451

Ocular Therapeutix Inc is categorized under Therapeutic X-Ray Apparatus and Tubes in Waltham, MA and active since 2009.

Ocular Therapeutix Inc was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Therapeutic X-Ray Apparatus and Tubes business, which does work in the B2B market, and is classified as a Therapeutic X-Ray Apparatus and Tubes, under code number 334517 by the NAICS.

If you are seeking more information, feel free to contact Jim Fortune at the company’s single location by writing to 204 2nd Avenue, Waltham, Massachusetts MA 02451 or by phoning (781) 895-3235. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ocular Therapeutix Inc
Contact Person: Jim Fortune
Address: 204 2nd Avenue, Waltham, Massachusetts 02451
Phone Number: (781) 895-3235
Website Address: ocutx.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Therapeutic X-Ray Apparatus and Tubes
SIC Code: 3844
NAICS Code: 334517
Share This Business:

Ocular Therapeutix Inc was started in 2009 to provide professional Therapeutic X-Ray Apparatus and Tubes under the SIC code 3844 and NAICS code 334517. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Jim Fortune for inquiries that concern Ocular Therapeutix Inc by calling the company number (781) 895-3235, as your correspondence is most welcome. Additionally, the physical location of the single location of Ocular Therapeutix Inc can be found at the coordinates 42.390742,-71.263557 as well as the street address 204 2nd Avenue in Waltham, Massachusetts 02451.

For its online presence, you may visit Ocular Therapeutix Inc’s website at ocutx.com and engage with its social media outlets through on Twitter and on Facebook.